Impact of treating iron deficiency, diagnosed according to hepcidin quantification, on outcomes after a prolonged ICU stay compared to standard care: a multicenter, randomized, single-blinded trial

BACKGROUND: Anemia is a significant problem in patients on ICU. Its commonest cause, iron deficiency (ID), is difficult to diagnose in the context of inflammation. Hepcidin is a new marker of ID. We aimed to assess whether hepcidin levels would accurately guide treatment of ID in critically ill anem...

Descripción completa

Detalles Bibliográficos
Autores principales: Lasocki, Sigismond, Asfar, Pierre, Jaber, Samir, Ferrandiere, Martine, Kerforne, Thomas, Asehnoune, Karim, Montravers, Philippe, Seguin, Philippe, Peoc’h, Katell, Gergaud, Soizic, Nagot, Nicolas, Lefebvre, Thibaud, Lehmann, Sylvain
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7885380/
https://www.ncbi.nlm.nih.gov/pubmed/33588893
http://dx.doi.org/10.1186/s13054-020-03430-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7885380/
https://www.ncbi.nlm.nih.gov/pubmed/33588893
http://dx.doi.org/10.1186/s13054-020-03430-3

Ejemplares similares